Our proprietary technology momentarily opens cellular membranes, enabling direct transfer of genetic material without electricity, viral vectors, or harsh chemicals. This approach preserves cell integrity, maximizes viability, and ensures reproducibility across both research and clinical scales.
Millions of cells flow through custom-designed devices, where precise forces create a brief, reversible membrane opening. This temporary state allows mRNA, plasmids, proteins, or CRISPR complexes to enter the cell efficiently without compromising health or function.
Broad Payload Compatibility
Supports delivery of mRNA, DNA, proteins, and gene-editing complexes — including complex, sequential, or high-volume routines.
Streamlined Workflow
Easily integrates into existing manufacturing processes without harsh buffers or extensive training.
Scalable by Design
Consistent performance from lab-scale to clinical-scale manufacturing with no protocol re-optimization.
Healthy Cells, Stronger Outcomes
Maintains phenotype, proliferation capacity, and therapeutic readiness.
By leveraging natural cell elasticity and mechanical responsiveness, our system mimics how cells adapt in vivo — producing stronger, more functional immune cells for therapeutic applications. This means shorter development timelines, reduced costs, and higher-quality outcomes at every stage.
Our technology supports a broad range of applications in cell and gene therapy, including:
CAR-T and TCR-T manufacturing
Ex vivo immune cell engineering
Gene editing and functional genomics
Protein delivery for regenerative medicine
